Anika Therapeutics
ANIK
#8667
Rank
HK$2.03 B
Marketcap
HK$152.29
Share price
1.49%
Change (1 day)
111.30%
Change (1 year)
Categories

EPS for Anika Therapeutics (ANIK)

EPS in 2026 (TTM): -HK$2.03

According to Anika Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$2.04. In 2025 the company made an earnings per share (EPS) of -HK$5.96 an increase over its 2024 EPS that were of -HK$30.21.

EPS history for Anika Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$2.03-65.98%
2025-HK$5.96-80.26%
2024-HK$30.21-31.86%
2023-HK$44.34448.54%
2022-HK$8.08-455.17%
2021HK$2.28-115.68%
2020-HK$14.52-195.85%
2019HK$15.1548.46%
2018HK$10.20-40.37%
2017HK$17.11-1.8%
2016HK$17.427.77%
2015HK$16.17-21.37%
2014HK$20.5674.67%
2013HK$11.7770.45%
2012HK$6.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.54-3,459.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$32.02-1,669.23%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Stryker Corporation
SYK
HK$76.36-3,842.31%๐Ÿ‡บ๐Ÿ‡ธ USA
STAAR Surgical
STAA
HK$0.55-126.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
HK$27.63-1,453.85%๐Ÿ‡บ๐Ÿ‡ธ USA